Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse. - Wikidata - awgldk - TriplyDB

Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.

Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.

http://www.wikidata.org/entity/Q34952794

about

Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release Nicotine as a potential neuroprotective agent for Parkinson's disease.Nicotinic receptor antagonists as treatments for nicotine abuse.Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Potential therapeutic uses of mecamylamine and its stereoisomers.Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

P2860

Q28576280-AB6162FB-2EB7-4A11-9CF5-29B287637846 Q33836376-78532575-C1C6-4F3E-AB50-AF6CF2147790 Q34281003-7517A169-412C-4D6B-A659-19B3F31120A7 Q34401397-0E10C180-D7C8-4D26-9FE4-BC65123AC694 Q34695631-87C17BCA-82DB-43A2-A5F9-28F11096EB34 Q34919642-F32DA6A7-66B7-4B3C-81D0-8ABF6EFC67EB Q35264378-EC1FF012-FEF8-4FF1-BAA7-2F4A0211F2B9 Q36949979-92722980-AD34-4DE4-85EE-9432AB3D8492 Q37052406-FA1885BA-D333-4D30-A2C3-753A02157953 Q37336577-28FD61B6-3476-4A15-A53B-2979506DABB3

P2860

Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.

http://www.wikidata.org/entity/Q34952794

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@ast

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@en

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@nl

type

label

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@ast

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@en

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@nl

prefLabel

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@ast

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@en

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@nl

P1433

Q34952794-E477D815-32DA-4962-8B40-6D4BBD8605FF

P1476

Q34952794-56737E73-E38B-47F3-981B-FD4C7EA211EA

P2093

Q34952794-02DA6BDA-9E85-49AF-9B6D-31909639DBD6

Q34952794-8E9769FE-EF53-428F-93A9-C854084B9D1D

P2860

Q34952794-03E95CE7-174E-453E-BA65-C3ECC5AF6585

Q34952794-48A51C24-F132-45E3-A514-DDC3E0BE798B

Q34952794-BFCADEAC-6E7D-4944-AC7F-31340611F59D

Q34952794-CC5454C6-D916-4087-B201-FCBAA0921E04

Q34952794-EA6A7D20-35EF-46E0-8CF7-9BE5373D70DD

Q34952794-F3F14003-BEEC-4F3A-BC90-658BA36950E6

Q34952794-FC7ADE7D-A0A7-48A7-9E33-7CB18256ABF0

P2888

Q34952794-D285E3C7-35D2-4F62-A35F-45919D4B486E

P304

Q34952794-AE05B264-1DAA-456A-A42B-753BDD2ABCB5

P31

Q34952794-ABCCDE66-C5AA-4F4D-8AC0-2829BBD39E6A

P356

Q34952794-331147F6-808B-4240-9B45-D2B1D14FC43A

P407

Q34952794-123E5EC5-1ABB-4623-BB84-0D21A237ABD6

P433

Q34952794-D3409B09-48C6-4D73-B6B2-87A69BD322B0

P478

Q34952794-60661D0E-9365-4A8A-BE40-BA2BB8D9F46F

P577

Q34952794-63435267-9C01-4F0A-9C76-64EAE6E6D58D

P5875

Q34952794-4EF97573-4777-497F-80B5-17E4D8904435

P6179

Q34952794-265E264F-29C0-481D-A5C0-FEA41327D939

P698

Q34952794-7E560C53-ABCD-4CEE-9D99-0F71F69D95B4

P921

Q34952794-048B6D5F-3BF2-43F4-95E8-DFAFD34F04CB

P932

Q34952794-2702A802-582E-4A6C-BC8B-D6361D352E68

P356

P1433

Neuropsychopharmacology

P1476

Targeting nicotinic receptor a ...... obacco dependence and relapse.

@en

P2093

Linda P Dwoskin

http://www.w3.org/2001/XMLSchema#string

Michael T Bardo

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence

Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat

N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity

The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.

Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.

Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors.

P2888

P304

244-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2008.157

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23659928

http://www.w3.org/2001/XMLSchema#string

P6179

1026688059

http://www.w3.org/2001/XMLSchema#string

P698

19079069

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

3089967

http://www.w3.org/2001/XMLSchema#string